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We present data relating to the interactome of MCM9 from the
nuclei of human cells. MCM9 belongs to the AAAþ superfamily,
and contains an MCM domain and motifs that may confer DNA
helicase activity. MCM9 has been shown to bind MCM8, and has
been implicated in DNA replication and homologous recombina-
tion. However, the mechanistic basis of MCM9’s role in DNA repair
is poorly understood, and proteins with which it interacts were
hitherto unknown. We performed tandem afﬁnity puriﬁcation of
MCM9 and its interacting proteins from nuclear extracts of human
cells, followed by proteomic analysis, thereby generating a set of
mass spectrometry data corresponding to the MCM9 interactome
[1]. The proteomic data set comprises 29 mass spectrometry RAW
ﬁles, deposited to the ProteomeXchange Consortium, and freely
available from the PRIDE partner repository with the data set
identiﬁer PXD000212. A set of 22 interacting proteins identiﬁed
from the proteomic data was used to create an MCM9-centered
interactive network diagram, using the Cytoscape program. These
data allow the scientiﬁc community to access, mine and explore
the human nuclear MCM9 interactome.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).vier Inc. This is an open access article under the CC BY-NC-ND license
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Dubject area Biology
ore speciﬁc sub-
ject areaProteomics, Molecular Cell Biologyype of data Mass spectrometry RAW data ﬁles from proteomic analysis of protein complexes
ow data were
acquiredMCM9-containing protein complexes were isolated, proteolytically digested,
separated by liquid chromatography, and analysed using an LTQ Velos ion-trap
mass spectrometer; raw data were searched against the human IPI database
using the Sequest algorithm [1].ata format Mass spectrometry Thermo RAW data ﬁles
xperimental
factorsExpression of tagged proteins in human cultured cells, preparation of nuclear
extracts, tandem protein puriﬁcationxperimental
featuresHuman MCM9 constructs, tagged at the N- or C-termini with FLAG-HA, were
expressed in HeLa S3 cells, and tandem afﬁnity puriﬁed. Complexes of MCM9
and associated proteins were analyzed by SDS-PAGE and silver staining, fol-
lowed by liquid chromatography-mass spectrometry [1]. Peptides and proteins
were identiﬁed by database searching.ata source
locationInstitute of Human Genetics (IGH), CNRS, 141 rue de la Cardonille, 34396
Montpellier, Franceata accessibility The data are provided in the public PRIDE repository with the dataset identiﬁer
PXD000212. The direct URL to access the data is http://www.ebi.ac.uk/pride/
archive/projects/PXD000212Value of the data
 The data revealed for the ﬁrst time the nuclear interactome of human MCM9.
 The data allow the research community to investigate the MCM9 interactome.
 The data act as a benchmark reference of MCM9 interactors for future studies.
 Mining these data could produce additional discoveries about MCM9 interactors.
 Analyzing the data could lead to further insights into MCM9 and its processes.1. Data
1.1. Mass spectrometry RAW data ﬁles
We present 29 mass spectrometry RAW data ﬁles that correspond to our proteomic analysis of the
human nuclear MCM9 interactome. These data ﬁles were deposited to the ProteomeXchange Con-
sortium via the PRIDE partner repository [2] with the data set identiﬁer PXD000212 (direct access:
http://www.ebi.ac.uk/pride/archive/projects/PXD000212). Data ﬁles with names 24770.RAW to
24784.RAW correspond to N-terminally tagged MCM9; 24786.RAW to 24801.RAW correspond to C-
terminally tagged MCM9.1.2. Protein interaction network
We present a protein interaction network centered on MCM9, generated using the Cytoscape
program (http://www.cytoscape.org; version 3.2.1) [3] (Fig. 1), based on our proteomic data. The
diagram comprises MCM9 plus 22 interacting proteins (combined from the N-terminal and C-
terminal FLAG-HA tagged puriﬁcations). Contaminant or background proteins have been removed.
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Full and detailed methods are described in our recent paper [1]. Here we present a summary for
each of the steps.
2.1. Generation of cell lines expressing FLAG-HA-tagged MCM9
Stable cell lines expressing double epitope (FLAG-HA; FH) tagged MCM9 at the N- or C-termini
were generated using the pOZ retroviral vectors. Vector design ensures tight coupling between the
expression of tagged MCM9 and the selection marker, the interleukin-2 receptor α chain (IL2Rα)
expressed at the cell surface [4]. Generation of transduction-competent retroviruses was performed
by transfecting the retroviral constructs into HEK-293 cells already expressing the retroviral structural
gene products required to release retroviral particles. For transduction, HeLa S3 cells were incubated
with viral particles containing pOZ-FH-MCM9, pOZ-MCM9-FH, or pOZ-FH (control). Transduced HeLa
S3 cells were selected using magnetic afﬁnity beads coupled to an anti-IL2Rα antibody. FollowingMismatch Repair Transcription
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Fig. 1. Nuclear interactome network for human MCM9. The network diagram, generated with Cytoscape software, shows
nuclear proteins (nodes), identiﬁed by tandem afﬁnity puriﬁcation and mass spectrometry analysis, that form a complex with
human MCM9. Proteins are represented by their ofﬁcial gene symbols, and attributed a color code according to their associated
biological processes or functions, as indicated. Note that connecting lines (edges) between proteins do not imply direct physical
association, but merely that proteins are members of a shared interactome centered on MCM9. A “live” interactive version of
this Cytoscape ﬁgure is available on the Data in Brief web page for this article.
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MCM9 in each clone tested by immunoblotting.
2.2. Tagged protein expression, and tandem afﬁnity puriﬁcation
For tandem afﬁnity puriﬁcation, a pool of clones for each construct that showed tagged MCM9
expression levels comparable to those of endogenous MCM9 were used. HeLa S3 cells expressing
FLAG-HA-tagged MCM9 at the N- or C-termini, or an empty vector expressing FLAG-HA alone, were
grown in exponential culture, and used to prepare soluble extracts of nuclear proteins according to
the Dignam method [5]. Isolation of tagged MCM9 and associated proteins was performed using a
tandem afﬁnity-puriﬁcation procedure based on immunoprecipitation of the FLAG and HA tags,
according to Nakatani and Ogryzko [4]. In step 1, the nuclear extracts were incubated with anti-FLAG
(M2) antibody-conjugated agarose beads. Beads were then washed extensively with FLAG-IP buffer
(20 mM Tris–KCl, pH 7.5, 230 mM KCl, 0.03% NP40, 0.07% Tween-20, 1 mM ATP, 5 mM MgCl2), then
bound proteins were eluted with two incubations in FLAG peptide. In step 2, the FLAG eluates were
incubated with anti-HA antibody-conjugated beads. Beads were washed extensively with HA-IP
buffer (20 mM Tris–KCl, pH 7.5, 150 mM KCl, 0.05% NP40, 0.1% Tween-20, 1 mM ATP, 5 mM MgCl2).
Bound proteins were eluted with two incubations in HA peptide. MCM9-containing protein com-
plexes were analyzed by SDS-PAGE, and revealed by silver staining.
2.3. Proteomic analysis
The silver-stained gel was sent to the Taplin Biological Mass Spectrometry Facility at Harvard
Medical School (http://taplin.med.harvard.edu/) for proteomic analysis. Each SDS-PAGE gel lane was
cut into slices, and each processed as a separate sample. Each gel slice was chopped into pieces of
approximately 1 mm3, then in-gel trypsin digested using a modiﬁcation of a standard procedure [6].
Gel pieces were washed and dehydrated with acetonitrile for 10 min, followed by removal of acet-
onitrile. Pieces were then completely dried in a SpeedVac centrifugal evaporator (Thermo Scientiﬁc).
Gel pieces were rehydrated using a solution of 50 mM ammonium bicarbonate (pH 8.0-8.2) con-
taining 12.5 ng/μl modiﬁed sequencing-grade trypsin (Promega) at 4 °C. After 45 min, excess trypsin
was removed and replaced with 50 mM ammonium bicarbonate, just covering the gel pieces, and
samples incubated at 37 °C overnight. Extraction of peptides then proceeded by removing the
ammonium bicarbonate solution, followed by one wash with a solution containing 50% acetonitrile,
1% formic acid. Extracts were then dried in a SpeedVac for approximately 1 h, then stored at 4 °C until
analysis. For analysis, samples were reconstituted in 5–10 μl HPLC solvent A (2.5% acetonitrile, 0.1%
formic acid). A nano-scale reverse-phase HPLC capillary column was prepared by packing 5 μm C18
spherical silica beads (Michrom Bioresources) into a fused silica capillary (125 μm inner
diameter 20 cm length) with a ﬂame-drawn tip [7]. After column equilibration, each sample was
loaded onto the column using a FAMOS autosampler (LC Packings, Dionex, Thermo Scientiﬁc). A
gradient was formed and peptides were eluted with increasing concentrations of solvent B (97.5%
acetonitrile, 0.1% formic acid). Upon elution, peptides were directly subjected to electrospray ioni-
zation and injection into an LTQ Velos ion-trap mass spectrometer (Thermo Scientiﬁc). Peptides were
detected, isolated and fragmented to produce a tandem mass spectrum of speciﬁc fragment ions for
each peptide.
2.4. Peptide and protein identiﬁcation
Identiﬁcation of peptides and proteins was performed by the data analysis pipeline of the Taplin
Facility. MS RAW data ﬁles were matched to entries in the human International Protein Index (IPI)
database [8] using the Sequest algorithm [9]. All accepted peptides have a cross-correlation (Xcorr)
score of at least 0.5. Identiﬁed peptides, Xcorr scores and corresponding protein identiﬁers (IDs) for
each sample were presented as HTML tables accessible via a web browser.
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Peptide data were copied from HTML tables and pasted into Microsoft Excel spreadsheets for
further processing and analysis. Identiﬁed proteins were mapped from their IPI to equivalent Swiss-
Prot [10] identiﬁers using the ID mapping functionality of the UniProt website (http://www.uniprot.
org/uploadlists/). Percentage sequence coverage, and numbers of non-distinct and distinct peptides
were calculated using the Protein Coverage Summarizer program from the Pan-Omics Research
division of the Paciﬁc Northwest National Laboratory (http://omics.pnl.gov/software/protein-cover
age-summarizer). UniProt IDs were used to generate a hyperlinked data table, as described [11]. A
subset of identiﬁed proteins was classiﬁed as being “background or contaminant” (at the level of gene
symbols) based on two reference sources: the set of “contaminant” proteins published by the
MitoCheck consortium [12], and the CRAPome database (http://www.crapome.org/) [13]. Protein
entries classiﬁed as “background or contaminants” were assigned labels in separate columns in the
data table, enabling them to be ﬁltered from the dataset, as required. A table of identiﬁed proteins,
and a spreadsheet containing all identiﬁed proteins and peptides for each sample are available as part
of our previous publication [1].Acknowledgments
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